Skip to Main Content

Good morning, everyone, and welcome to another working week. And nice to see you again after an extended weekend respite on the side of the pond. The time flew by, did it not? We enjoyed special time with a couple of our short people and hope that you also had a chance to indulge your own priorities. Now, though, the time has come to return to the usual routines of meetings, deadlines and the like. So here are some tidbits. Hope your day goes well and do keep in touch …

IQWiG, the independent authority in Germany that evaluates new drugs, criticized a lack of data directly comparing  new immunotherapies for treating bladder cancer because doctors could be overwhelmed or misled by available information, Reuters reports. The agency wants regulations changed so that companies are required to conduct head-to-head studies.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!